GridAI grants director 100,000-share stock award

Q: How many shares did GRDX director Edward Borkowski receive for director fees?

A total of 17,079 common shares were issued under a settlement agreement effective October 26, 2026, in full satisfaction of $94,790.77 in accrued and unpaid director fees for April 2024 through January 2025. The share count was calculated using the $5.55 closing bid price and rounded down to the nearest whole share.

Q: What equity awards did GRDX director Edward Borkowski receive?

He received 100,000 restricted stock units, which vested in full on October 26, 2026, with each unit representing the right to receive one common share. He also received options for 100,000 shares at a $5.55 exercise price, exercisable in full on the grant date.

The director-fee settlement issued 17,079 shares in full satisfaction of $94,790.77 in accrued fees, using a $5.55 closing bid price.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

On October 26, 2026, GridAI Technologies Corp. (GRDX) granted director Edward Borkowski 100,000 restricted stock units, which vested in full that day; each unit represents the right to receive one common share. He also received options for 100,000 shares at a $5.55 exercise price, exercisable in full on the grant date. Separately, 17,079 common shares were issued under a settlement agreement in full satisfaction of $94,790.77 in accrued director fees for April 2024 through January 2025; the share count used the $5.55 closing bid price, rounded down.

Insider Trade Summary

Grant/Award: 217,079 shares

Grant/Award 3 txns

Insider BORKOWSKI EDWARD

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy) ^F3	100,000	$0.00	$0.00
Grant/Award	Common Stock ^F1	100,000	$0.00	$0.00
Grant/Award	Common Stock ^F2	17,079	$5.55	$95K

Holdings After Transaction: Stock Option (right to buy) — 100,000 contracts (Direct); Common Stock — 177,327 shares (Direct)

Footnotes (3)

F1. On October 26, 2026, the Reporting Person was granted 100,000 additional restricted stock units under the Issuer's 2020 Omnibus Equity Incentive Plan, as amended, in recognition of service on the Board of Directors, which vested in full on the date of the grant. Each restricted stock unit represents the right to receive one share of common stock.
F2. Represents shares of common stock issued under the Issuer's 2020 Omnibus Equity Incentive Plan, as amended, pursuant to a Settlement Agreement and Release effective October 26, 2026, in full satisfaction of $94,790.77 of accrued and unpaid director fees for the period from April 2024 to January 2025. The number of shares equals $94,790.77 divided by $5.55, the consolidated closing bid price of the common stock on The Nasdaq Stock Market on October 26, 2026, rounded down to the nearest whole share.
F3. Stock option granted on October 26, 2026 under the Issuer's 2020 Omnibus Equity Incentive Plan, as amended, with an exercise price equal to the Nasdaq closing price of the common stock on the date of grant. The option was granted immediately and is exercisable in full on the date of the grant.

Key Figures

Restricted stock units granted: 100,000 restricted stock units Options granted: 100,000 options Option exercise price: $5.55 per share +3 more

6 metrics

Restricted stock units granted 100,000 restricted stock units Vested in full on October 26, 2026

Options granted 100,000 options Each option is exercisable for one common share

Option exercise price $5.55 per share Options granted October 26, 2026

Common shares issued for director fees 17,079 shares Under a settlement agreement effective October 26, 2026

Accrued and unpaid director fees $94,790.77 Satisfied in full with the share issuance

Consolidated closing bid price $5.55 per share Used to calculate the shares issued for director fees on October 26, 2026

Key Terms

restricted stock units, Settlement Agreement and Release, accrued and unpaid director fees, exercise price

4 terms

restricted stock units financial

"granted 100,000 additional restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Settlement Agreement and Release financial

"pursuant to a Settlement Agreement and Release effective October 26, 2026"

accrued and unpaid director fees financial

"of accrued and unpaid director fees for the period"

exercise price financial

"with an exercise price equal to the Nasdaq closing price"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did GRDX director Edward Borkowski receive for director fees?

A total of 17,079 common shares were issued under a settlement agreement effective October 26, 2026, in full satisfaction of $94,790.77 in accrued and unpaid director fees for April 2024 through January 2025. The share count was calculated using the $5.55 closing bid price and rounded down to the nearest whole share.

What equity awards did GRDX director Edward Borkowski receive?

He received 100,000 restricted stock units, which vested in full on October 26, 2026, with each unit representing the right to receive one common share. He also received options for 100,000 shares at a $5.55 exercise price, exercisable in full on the grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/28/2026 - 09:52 PM EDT Accepted by SEC EDGAR 10/28/2026 - 09:51 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BORKOWSKI EDWARD

(Last)

(First)

(Middle)

C/O GRIDAI TECHNOLOGIES CORP.

433 PLAZA REAL, SUITE 275

(Street)

BOCA RATON

FLORIDA

33432

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GridAI Technologies Corp. [ GRDX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/26/2026		A		100,000⁽¹⁾	A	$0.00	160,248	D
Common Stock	10/26/2026		A		17,079⁽²⁾	A	$5.55⁽²⁾	177,327	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$5.55⁽³⁾	10/26/2026		A		100,000		10/26/2026⁽³⁾	10/26/2026	Common Stock	100,000	$0.00	100,000	D

Explanation of Responses:

1. On October 26, 2026, the Reporting Person was granted 100,000 additional restricted stock units under the Issuer's 2020 Omnibus Equity Incentive Plan, as amended, in recognition of service on the Board of Directors, which vested in full on the date of the grant. Each restricted stock unit represents the right to receive one share of common stock.

2. Represents shares of common stock issued under the Issuer's 2020 Omnibus Equity Incentive Plan, as amended, pursuant to a Settlement Agreement and Release effective October 26, 2026, in full satisfaction of $94,790.77 of accrued and unpaid director fees for the period from April 2024 to January 2025. The number of shares equals $94,790.77 divided by $5.55, the consolidated closing bid price of the common stock on The Nasdaq Stock Market on October 26, 2026, rounded down to the nearest whole share.

3. Stock option granted on October 26, 2026 under the Issuer's 2020 Omnibus Equity Incentive Plan, as amended, with an exercise price equal to the Nasdaq closing price of the common stock on the date of grant. The option was granted immediately and is exercisable in full on the date of the grant.

	/s/ Edward Borkowski	10/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR